In this observational retrospective study, expression of possible cancer-related genes was measured in patients with a pathological diagnosis of superficial bladder cancer. Further measurements were made in those who subsequently developed muscle-invasive cancer. Seven of the 45 patients with superficial bladder cancer progressed to muscle-invasive cancer. Expression of fatty acid binding protein 5 (FABP5), poly(A) binding protein cytoplasmic 1 (PABPC1), DEAD box polypeptide 5 (DDX5), splicing factor 3b subunit 1 (SF3B1), murine mammary tumour integration site 6 (EIF3S6), tropomyosin 2β (TPM2), transgelin (TAGLN) and cyclin-dependent kinase-associated protein (Cks2) genes was measured in bladder samples using real-time reverse transcription—polymerase chain reaction. FABP5, PABPC1, DDX5, SF3B1, EIF3S6 and Cks2 expression levels were significantly increased, and TPM2 and TAGLN were significantly decreased, in superficial bladder cancer compared with normal bladder tissue. In patients who developed muscle-invasive cancer, the Cks2 gene showed significantly increased expression after, compared with before, invasion. The Cks2 gene may have potential as a biomarker for predicting superficial bladder cancer progression to muscle-invasive cancer.
JemalASiegelRXuJ: Cancer statistics, 2010. CA Cancer J Clin2010; 60: 277–300.
2.
SolowayMSSoferMVaidyaA: Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol2002; 167: 1573–1583.
3.
SaadAHanburyDCMcNicholasTA: A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int2002; 89: 369–373.
4.
SteinJPLieskovskyGCoteR: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol2001; 19: 666–675.
5.
MatsumotoMKawakamiKEnokidaH: CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer. Int J Mol Med2010; 26: 241–247.
6.
MoriKEnokidaHKagaraI: CpG hypermethylation of collagen type I α 2 contributes to proliferation and migration activity of human bladder cancer. Int J Oncol2009; 34: 1593–1602.
7.
KawakamiKEnokidaHTachiwadaT: Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep2006; 16: 521–531.
8.
BolenzCLotanY: Translational research in bladder cancer: from molecular pathogenesis to useful tissue biomarkers. Cancer Biol Ther2010; 10: 407–415.
9.
BryanRTTselepisC: Cadherin switching and bladder cancer. J Urol2010; 184: 423–431.
10.
McConkeyDJLeeSChoiW: Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol Oncol2010; 28: 429–440.
11.
PatraDDunphyWG: Xe-p9, a Xenopus Suc1/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase-promoting complex at mitosis. Genes Dev1998; 12: 2549–2559.
12.
PatraDWangSXKumagaiA: The Xenopus Suc1/Cks protein promotes the phosphorylation of G2/M regulators. J Biol Chem1999; 274: 36839–36842.
13.
Martinsson-AhlzénHSLiberalVGrünenfelderB: Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol2008; 28: 5698–5709.
14.
WakuiMShiigaiT: Urinary tract cancer screening through analysis of urinary red blood cell volume distribution. Int J Urol2000; 7: 248–253.
15.
HerrHWSchneiderM: Outpatient flexible cystoscopy in men: A randomized study of patient tolerance. J Urol2001; 165: 1971–1972.
16.
WuXR: Urothelial tumorigenesis: A tale of divergent pathways. Nat Rev Cancer2005; 5: 713–725.
17.
ShariatSFChadeDCKarakiewiczPI: Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol2010; 183: 68–75.
18.
SiegenthalerGHotzRChatellard-GruazD: Characterization and expression of a novel human fatty acid-binding protein: the epidermal type (E-FABP). Biochem Biophys Res Commun1993; 190: 482–487.
19.
O'ShaughnessyRFSeeryJPCelisJE: PA-FABP, a novel marker of human epidermal transit amplifying cells revealed by 2D protein gel electrophoresis and cDNA array hybridisation. FEBS Lett2000; 486: 149–154.
20.
Kannan-ThulasiramanPSeachristDDMahabeleshwarGH: Fatty acid-binding protein 5 and PPARβ/δ are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J Biol Chem2010; 285: 19106–19115.
21.
FangLYWongTYChiangWF: Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol Med2010; 39: 342–348.
22.
GrangeTde SaCMOddosJ: Human mRNA polyadenylate binding protein: evolutionary conservation of a nucleic acid binding motif. Nucleic Acids Res1987; 15: 4771–4787.
23.
CraigAWHaghighatAYuAT: Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature1998; 392: 520–523.
24.
HlochPSchiednerGStahlH: Complete cDNA sequence of the human p68 protein. Nucleic Acids Res1990; 18: 3045.
25.
IggoRGoughAXuW: Chromosome mapping of the human gene encoding the 68-kDa nuclear antigen (p68) by using the polymerase chain reaction. Proc Natl Acad Sci USA1989; 86: 6211–6214.
26.
WilsonBJBatesGJNicolSM: The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol2004; 5: 11.
27.
NicolSMCausevicMPrescottAR: The nuclear DEAD box RNA helicase p68 interacts with the nucleolar protein fibrillarin and colocalizes specifically in nascent nucleoli during telophase. Exp Cell Res2000; 257: 272–280.
28.
MiyazakiSImataniABallardL: The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics1997; 46: 155–158.
29.
WangCChuaKSeghezziW: Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev1998; 12: 1409–1414.
30.
ZhuJBilanPJMoyersJS: Rad, a novel Ras-related GTPase, interacts with skeletal muscle β-tropomyosin. J Biol Chem1996; 271: 768–773.
31.
KobayashiRKubotaTHidakaH: Purification, characterization, and partial sequence analysis of a new 25-kDa actin-binding protein from bovine aorta: A SM22 homolog. Biochem Biophys Res Commun1994; 198: 1275–1280.
32.
AssinderSJAuEDongQ: A novel splice variant of the β-tropomyosin (TPM2) gene in prostate cancer. Mol Carcinog2010; 49: 525–531.
33.
ShieldsJMRogers-GrahamKDerCJ: Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem2002; 277: 9790–9799.
34.
YangZChangYJMiyamotoH: Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol Endocrinol2007; 21: 343–358.
35.
Urbanowicz-KachnowiczIBaghdassarianNNakacheC: Ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells. Int J Cancer1999; 82: 98–104.
36.
GiannopoulosAManousakasTGounariA: Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. J Urol2001; 166: 470–475.
37.
MahnertBTauberSKriegmairM: Measurements of complement factor H-related protein (BTA—TRAK assay) and nuclear matrix protein (NMP22 assay)–useful diagnostic tools in the diagnosis of urinary bladder cancer?Clin Chem Lab Med2003; 41: 104–110.
